2016
DOI: 10.1186/s12985-016-0557-8
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral activity of micafungin against enterovirus 71

Abstract: BackgroundEnterovirus 71 (EV71) is a major causative agent of hand-foot-mouth disease (HFMD) and also causes severe neurological complications, leading to fatality in young children. However, no effective therapy is currently available for the treatment of this infection.MethodsWe identified small-molecule inhibitors of EV71 from a screen of 968 Food and Drug Administration (FDA)-approved drugs, with which clinical application for EV71-associated diseases would be more feasible, using EV71 subgenomic replicon … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 33 publications
(34 citation statements)
references
References 39 publications
0
34
0
Order By: Relevance
“…at 89.2%, demonstrating that ITZ strongly suppresses viral RNA replication or polyprotein processing [ 87 ]. Another study evaluated a total of 968 FDA-approved drugs as potential antivirals using both EV-71 and CV-B3 replicon systems [ 96 ]. Vero cells were transfected with EV-71 replicon RNA and simultaneously treated with the compounds at 10 µM concentration.…”
Section: Non-enveloped Virusesmentioning
confidence: 99%
See 1 more Smart Citation
“…at 89.2%, demonstrating that ITZ strongly suppresses viral RNA replication or polyprotein processing [ 87 ]. Another study evaluated a total of 968 FDA-approved drugs as potential antivirals using both EV-71 and CV-B3 replicon systems [ 96 ]. Vero cells were transfected with EV-71 replicon RNA and simultaneously treated with the compounds at 10 µM concentration.…”
Section: Non-enveloped Virusesmentioning
confidence: 99%
“…Similar results were obtained for Vero cells transfected with CV-B3 replicon RNA. Nevertheless, the precise mechanism of the antiviral effect of Micafungin on EV-71 was not determined [ 96 ].…”
Section: Non-enveloped Virusesmentioning
confidence: 99%
“…MTT assay was used for measuring cell viability as described previously [40]. Cell viability was calculated as a percentage relative to the control.…”
Section: Cell Viability Assaymentioning
confidence: 99%
“…Plasmids p53CB3-LUC and pRibFluc-EV71, which contain the firefly luciferase gene in place of the P1 capsid coding region of CVB3 and EV71 viral genomes, were kindly provided by Frank J. M. van Kuppeveld (Utrecht University, The Netherlands) [23,24]. Synthesis of CVB3 and EV71 replicon RNAs and replicon assays were performed as previously described [40]. Briefly, HeLa cells (3×10 5 cells/well) on a 6-well plate were transfected with 0.4 μg of replicon RNA, split into 96well plates (2×10 4 cells/well), and simultaneously treated with nucleosides, nucleobases or pyrimidine biosynthetic intermediates in the presence of gemcitabine.…”
Section: Replicon Assaymentioning
confidence: 99%
“…Enterovirus 71 (EV71) and Coxsackie virus A16 are common etiological agents of HFMD, among which, EV71 can cause severe central nervous system damage and multiple-organ dysfunction and even become life threatening (2). EV71 infection can cause immune system dysfunction; T lymphocyte subsets can secrete a variety of inflammatory cytokines, which can worsen the disease symptoms (3).…”
Section: Introductionmentioning
confidence: 99%